Sunday, August 17, 2025

Latest

Company Overview:

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in twelve countries spanning five continents.

[stock_market_chart symbol=”TLRY” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Current Share Price$61.50
Market Capitalization (in Millions)$5,987.49
Last Quarter (Share Data)6/30/2019
Shares Outstanding (in Millions)97.36
Options (in Millions)6.01
Warrants (in Millions)
Fully Diluted (in Millions)103.37

Enterprise Value (in Millions)$6,466.90
TTM Revenue$122.12
TTM Growth Margin %28.66%
TTM Operating Expenses$173.06
TTM OCF-$207.76
P/S TTM49.03
P/S (Last Quarter Run Rate)32.61

Key Balance Sheet Information (in Millions $CAD):

CYQ2'18CYQ3'18CYQ4'18CYQ1'19CYQ2'19
Cash$25.33$104.25$487.26294.21184.55
Biological Assets
Inventory$6.75$12.11$16.2148.7175.32
Total Assets$106.48$223.80$656.671,076.601,024.13
Net Tangible Assets$105.08$222.41$652.18$556.17$537.19
Intangibles/Goodwill$1.40$1.39$4.49520.42486.94
Total Liabilities$71.24$35.69$459.01694.68663.96

Key Operating Items (Quarterly in Millions $CAD):

CYQ2'18CYQ3'18CYQ4'18CYQ1'19CYQ2'19
Revenue$9.74$10.05$43.13$23.04$45.90
Change in Fair Value of Biologial Assets
Gross Margin$4.18$3.07$14.28$5.39$12.27
Marketing and Sales$3.31$3.49$15.37$7.82$14.37
Investor Relations
Total Operating Expenses$15.17$23.08$71.93$33.26$44.79
Operating Cash Flow (Quarterly)-$2.91-$23.54-$19.81$21.41-$85.39
Investing Cash Flow (Quarterly)-$28.95-$24.59-$45.08-$70.88-$29.08
Financing Cash Flow (Quarterly)-$1.16$3.40$628.76-$630.25$4.96

Listing Statement

All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.

Video Articles

Barrick Q2 Earnings: Gold Production Dives

Agnico Q2 Earnings: Record Free Cash Flow Puts Them In Net Cash Position

Minera Alamos: Stock Craters On Deal To Buy Equinox’s Nevada Assets

Recommended

First Majestic Posts Record Free Cash Flow In Second Quarter

Silver47 Identifies 35 Mineralized Prospects Across 55 Km Trend At Red Mountain